Erlotinib hydrochloride | definition of erlotinib hydrochloride by Medical dictionary
erlotinib hydrochloride (ĕr′lō′tə-nĭb)
A tyrosine kinase inhibitor used in the treatment of certain forms of non-small cell lung cancer and pancreatic cancer.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.
References in periodicals archive
Erlotinib hydrochloride (ERLO) is an epidermal growth factor receptor inhibitor that was approved by the United States Food and Drug Administration (FDA) in 2004 for the treatment of non-small-cell lung cancer and its anticancer effects promised hope in various preclinical models.
Bioequvalence of new generic formulation of erlotinib hydrochloride 150 mg tablets versus Tarceva[R] in healthy volunteers under fasting conditions.
TRIBUTE: a phase III trial of erlotinib hydrochloride
(OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.